News from Second Genome, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 03, 2017, 08:00 ET Second Genome Launches Study of the Relationship Between Microbiome and Central Nervous System in Autism Spectrum Disorders

Second Genome, Inc., a leader in the development of novel medicines through innovative microbiome science, and the Stanford University School of...


Dec 09, 2016, 08:00 ET Second Genome Announces Appointments in Human Resources, Finance to Support Corporate Growth

Second Genome, Inc., a leader in the development of novel medicines through innovative microbiome science, announced today that it has appointed...


Jul 13, 2016, 08:00 ET Second Genome Appoints Glenn Nedwin, Ph.D., as Chief Executive Officer

Second Genome, Inc., a privately-held biopharmaceutical company developing novel medicines through innovative microbiome science, today announced...


Jan 12, 2015, 08:00 ET Second Genome Advances Lead Microbiome Drug Development Program in Phase I Clinical Trial as a Treatment for Inflammatory Bowel Disease

 Second Genome, Inc., a pioneer in the development of novel medicines through innovative microbiome science, announced today that the company...


Oct 07, 2014, 08:00 ET Second Genome and Mayo Clinic Enter Collaboration to Develop Microbiome Therapeutics in Multiple Diseases

 Second Genome, Inc., a leader in the development of novel medicines through innovative microbiome science, has entered into an extensive...


Jun 05, 2013, 08:00 ET Second Genome Announces Agreement with Janssen on Microbiome Drug Discovery in Ulcerative Colitis

 Second Genome, Inc. announced today that the company has entered into an agreement with Janssen Biotech, Inc. (Janssen) focused on microbiome...